World's Best Scientists 2026 revealed!
Alain Fourquet

Alain Fourquet

D-Index & Metrics

Medicine

D-Index
84
Citations
27090
World Ranking
15048
National Ranking
484

Alain Fourquet publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alain Fourquet sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 588 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alain Fourquet D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alain Fourquet sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alain Fourquet is affiliated with the Institute Curie in France. Their research primarily focuses on medical fields related to cancer, particularly breast cancer, and radiation therapy. Throughout their career, they have published extensively in areas intersecting medicine and biochemistry, genetics and molecular biology.

The main fields of study associated with their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields of their research encompass:

  • Cancer Research
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine
  • Radiation

The primary research topics they cover are:

  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Breast Lesions and Carcinomas
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • PARP inhibition in cancer therapy
  • BRCA gene mutations in cancer

Alain Fourquet has contributed to a number of recent papers, including:

  • Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial, 2020, The Lancet Oncology
  • Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer, 2022, JAMA Oncology
  • A Radiation Therapy Contouring Atlas for Cardiac Conduction Node Delineation, 2021, Practical Radiation Oncology
  • Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925, 2021, JNCI Journal of the National Cancer Institute

Throughout their career, the scientist has worked frequently with several co-authors, including:

  • Youlia Kirova
  • Pierre Loap
  • Kim Cao
  • F. Laki
  • Delphine Loirat

The common publication venues for Alain Fourquet's research include:

  • Cancer/Radiothérapie
  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Cancers

Best Publications

  • Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans

  • Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

    Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans

  • Internal mammary and medial supraclavicular irradiation in breast cancer

    P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen

  • Male breast cancer

    Ian S Fentiman;Alain Fourquet;Gabriel N Hortobagyi

  • Age as prognostic factor in premenopausal breast carcinoma.

    A. de la Rochefordière;F. Campana;J. Fenton;J.R. Vilcoq

  • Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    Harry Bartelink;Philippe Maingon;Philip Poortmans;Caroline Weltens

  • Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up.

    Alain Fourquet;François Campana;Brigitte Zafrani;Véronique Mosseri

  • Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

    S.M. Scholl;A. Fourquet;B. Asselain;J.Y. Pierga

  • The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial

    Conny Vrieling;Laurence Collette;Alain Fourquet;Willem J. Hoogenraad

  • Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

    L. J. Solin;J. Kurtz;A. Fourquet;R. Amalric

  • Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer

    P.A. Cabanes;R.J. Salmon;J.R. Vilcoq;J.C. Durand

  • Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

    Elisabeth Luporsi;Fabrice André;Frédérique Spyratos;Pierre-Marie Martin

  • The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.

    Fatima Cardoso;Sibylle Loibl;Olivia Pagani;Alessandra Graziottin

  • Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

    Heather A. Jones;Ninja Antonini;Augustinus A.M. Hart;Johannes L. Peterse

  • Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.

    Christine Louis-Sylvestre;Krishna Clough;Bernard Asselain;Jacques René Vilcoq

  • Is obesity an independent prognosis factor in woman breast cancer

    Bilal Majed;Thierry Moreau;Kamel Senouci;Rémi J. Salmon

  • Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

    Sandra Collette;Laurence Collette;Tom Budiharto;Jean-Claude Horiot

  • Contralateral breast cancer: annual incidence and risk parameters.

    P Broët;A de la Rochefordière;S M Scholl;A Fourquet

  • Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

    Dominique Stoppa-Lyonnet;Yan Ansquer;Hélène Dreyfus;Chantal Gautier

  • O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

    H. Struikmans;H. Bartelink;J.C. Horiot;P.M. Poortmans

Frequent Co-Authors

Bernard Asselain
Bernard Asselain Institute Curie
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Xavier Sastre-Garau
Xavier Sastre-Garau Institute Curie
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Philip Poortmans
Philip Poortmans University of Antwerp
Jean-Yves Pierga
Jean-Yves Pierga Institute Curie
Laurence Collette
Laurence Collette European Organisation for Research and Treatment of Cancer
Véronique Diéras
Véronique Diéras Institute Curie
Olivier Delattre
Olivier Delattre PSL University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career pathways related to medicine in the USA reveals several flexible online options. For those seeking a fast track to advanced nursing roles, direct entry np programs for non nurses online are becoming increasingly popular. These programs allow individuals without a nursing background to quickly gain specialized qualifications.

If you're just starting out, you might be interested in the easiest nursing programs to get into. These institutions provide accessible routes for students who may not meet all the traditional entry requirements but still want to pursue a rewarding healthcare career.

Not all healthcare-related paths require years of study. For example, those interested in the administrative side of medicine can find reputable medical billing and coding schools that accept fafsa, making education more affordable with financial aid options.

Finally, some nursing programs offer greater flexibility in admissions criteria. If you want to skip standardized entry exams, consider a nursing school that doesn't require teas testing, which can simplify your application process.

Best Scientists Citing Alain Fourquet

Trending Scientists

Recently Published Articles